Jules A. Musing - 01 Jul 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Reporting relationship: Director
Issuer ticker: TXMD
Reported as of: 01 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2021, 18:09:43 UTC
Next SEC filing: 12 Aug 2021
Source filing: View source filing
Reporting owner signature: /s/ Jules A. Musing

Key filing fact

Jules A. Musing filed Form 4 for TherapeuticsMD, Inc. (TXMD) on 02 Jul 2021.

Key facts

This page summarizes Jules A. Musing's Form 4 filing for TherapeuticsMD, Inc. (TXMD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2021, 18:09.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TXMD transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +99,174
Change %
Price: $0.000000
Shares after: 99,174
Date: 01 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 99,174
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest on July 1, 2022.